Phytohemagglutinin, the glycoprotein lectin of the common bean, Phaseolus vulgaris, has both high-mannose (Man&*GlcNAc2) and modified oligosaccharide side chains. The modified side chains have glucosamine, mannose, fucose, and xylose in the molar ratios 2:3.8:O.6:0.5, and are resistant to hydrolysis by endoglycosidase H. Synthesis and processing of side chains in the presence of 1-deoxynojirimycin, an inhibitor of a-glucosidase, results in the formation of chains which are all alike. They are sensitive to endoglycosidase H, do not contain fucose, and are largely resistant to a-mannosidase. This indicates that they are probably highmannose chains blocked by terminal glucose residues. Synthesis and processing of side chains in the presence of swainsonine, an inhibitor of a-mannosidase II, results in the formation of normal high-mannose chains, and of modified chains which contain fucose residues, are resistant to endoglycosidase H, and can be distinguished from normal modified chains only by the presence of extra mannose residues.
Glycoproteins contain two types of asparagine-linked oligosaccharide side chains: high-mannose chains with the general formula Man9GlcNAc2 and modified chains in which mannose residues have been removed and other glycosyl residues have been added. Modifications of the asparagine-linked oligosaccharide occur mostly in the Golgi complex, after transfer of the oligosaccharide from the lipid-donor to the nascent polypeptide chain in the rough ER. This processing leads to a great variety of oligosaccharide side chains which have been extensively studied in animal cells (for review, see 18) . Relatively little is known about the structure and processing of the modified oligosaccharide side chains of plant glycoproteins. We study of the biosynthesis of the oligosaccharide side-chains of the seed storage protein PHA3, a tetrameric glycoprotein lectin which accounts for 5 to 10% of the total seed protein in the common bean (Phaseolus vulgaris L.). Each polypeptide of PHA has two different classes of asparagine-linked oligosaccharides: one is of the high mannose type, and one is of the modified type and contains GlcNAc, Man, Fuc, and Xyl in the molar ratios 2:3.8:0.6:0.5 (29) . The synthesis of the modified side chain starts in the ER, where PHA polypeptides are synthesized, and the modifications occur in the Golgi complex, where the protein passes en route to the protein bodies (4, 27, 28) . These modifications include the removal ofmannose residues and the addition offucose, xylose, and peripheral GlcNAc residues. Accumulation of PHA in the protein-bodies is accompanied by the removal of the peripheral GlcNac residues (28) . To gain insight into the importance ofeach processing step for subsequent steps, we have studied the processing events in the presence of 1-deoxynojirimycin and swainsonine. DONJM prevents the removal of the glucose residues from the Glc3Man9GlcNAc2 oligosaccharide which is transferred in the ER from the lipid donor to the nascent polypeptide chain (12, 21, 22) . While we have no specific evidence that the precursors of the high-mannose chains of PHA carry three glucose residues, experiments with plant systems show that the Glc3Man9GlcNAc2 precursor exists in plant cells (13, 14, 19, 24) as it does in animal cells. In animal cells, swainsonine inhibits a-mannosidase II (25) , preventing the removal of the a-1,3 and a-1,6-linked mannose residues which are normally removed after the a-1,2-linked residues have been taken off by amannosidase I from the high-mannose oligosaccharide chains. The results presented here show that DONJM alters the processing of the high-mannose chains of PHA by inhibiting the incorporation of fucose and preventing the removal of mannose residues. Swainsonine has less effect on processing, and the modified oligosaccharide sidechains which are formed can only be distinguished by the presence of additional mannose residues. The attachment of peripheral GlcNAc residues in the Golgi apparatus, and their subsequent removal in the protein bodies still occur in the modified chains synthesized in the presence of swainsonine.
MATERIALS AND METHODS Materials. Plants of Phaseolus vulgaris L. cv Greensleeves were grown in a greenhouse as described (3 (Fig. 3B) (Table I) show that DONJM inhibited the incorporation of '4C-amino acids into PHA by 37%, while swainsonine had no effect. Furthermore, DONJM inhibited incorporation of fucose very severely, but swainsonine had only a small effect.
Effect of Inhibitors on Incorporation of Terminal GIcNAc. The ratio of terminal GlcNAc in the oligosaccharide sidechain to GlcNAc in chitobiose can be assayed by digesting GlcN-labeled oligosaccharides with ,B-N-acetylglucosaminidase, and separating the products on Bio-Gel P4. The glycopeptides used in these experiments were obtained from PHA isolated from cotyledons which had been labeled for 2'/2 h only, after a 2'/2-h pretreatment with DONJM or swainsonine. By using the short labeling time, the PHA oligosaccharide chains of the modified class were still in the precursor form, with the transient peripheral GlcNAc residues acquired in the Golgi apparatus still attached (28) .
Treatment of control glycopeptides with fl-N-acetylglucosaminidase caused the release of 36% ofthe radioactivity as free GlcNAc (Fig. 4A) . Treatment ofglycopeptides synthesized in the presence of DONJM and of swainsonine caused the release of 17 and 33%, respectively, of the radioactive GlcNAc residues (Fig. 4 , B and C). Thus, swainsonine has little effect on the attachment of peripheral GlcNAc residues, while DONJM inhibits this process. The inhibition of GlcNAc incorporation by DONJM is less complete than the inhibition of fucose incorporation.
Swainsonine Fig. 5A . GP, remains unlabeled, since it does not contain fucose. When PHA is synthesized in the presence ofswainsonine, GP2 is considerably larger than in the control (Fig. 5B) . Treatment with a-mannosidase does not affect the position of pGP2 because the terminal mannose residues are blocked by GlcNAc residues (28) . However, GP2 is partially degraded by a-mannosidase and in both control and swainsonine-treated samples shifts to the same position. This result is interpreted to mean that GP2 synthesized in the presence of swainsonine has additional mannose residues with respect to normal GP2. This was confirmed by experiments in which GP, and GP2 were isolated from PHA labeled with [3HJmannose, separated from each other and then digested with a-mannosidase. The free mannose can then be recovered as a peak around fractions 62 to 64. The percentage radioactivity in free mannose gives an indication of the degree to which mannose residues have been removed in situ as part of the oligosaccharide modification process. The implicit assumption is that the long labeling time (20 h) has allowed all mannose residues to become equally labeled. To separate GP, from GP2
in the swainsonine-treated samples (they form a single peak, instead of two peaks; see Fig. IC ), the mixture was first digested with endo H, to convert GP, to an oligosaccharide which could then be separated from the larger GP2 (see Fig. 3 tides synthesized in the presence of DONJM were treated with a-mannosidase, we observed only a small shift in the glycopeptide peak (see Fig. 2B ) indicating that part of the terminal mannose residues present on each sidechain are blocked. Incubation of [3H]mannose-labeled glycopeptides, synthesized in the presence of DONJM, with a-mannosidase resulted in a small shift of the glycopeptide peak, and the release of about 20% of radioactivity as free mannose (Fig. 6) . Assuming that all the mannose residues are uniformly labeled, then a maximum of 56% of radioactivity would be released from the [3H]mannoselabeled precursor Glc3Man9GlcNac2 by a-mannosidase. We interpret our results shown in Figure 6 to mean that the oligosaccharide chains of PHA synthesized in the presence of DONJM carry the three glucose residues and are partially processed in the two a-mannosyl branches which are not blocked by glucose. This partial processing probably involves only the sidechains destined in normal conditions to become GP2. DISCUSSION Elbein et al. (7) were the first to show that swainsonine interferes with the formation of complex asparagine-linked oli- gosaccharides. This interference is due to the inhibition by swainsonine of Golgi mannosidase 11 (25) and results in the formation of hybrid oligosaccharides (2, 25, 26 (27, 28) . About half of the oligosaccharide chains of PHA (GP2) undergo these processing events, while the other 50% (GP,) are not modified and are present as high-mannose chains on mature PHA present in the protein bodies (29) . The data presented here show that about halfofthe side-chains ofmature PHA synthesized in the presence of swainsonine are partially resistant to a-mannosidase and totally resistant to endo H treatment, similar to GP2 in normal PHA (Figs. 2 and 3 ). There is no inhibition of the incorporation of fucose, similar to the results obtained by Gross et al ( 11) Newly synthesized PHA present in the endoplasmic reticulum has only high-mannose chains, thus the precursors of GP, and GP2 coelute as a single peak on the Bio-Gel P4 column in a position corresponding to that of the mature high-mannose GP, (28) . However, GP2 synthesized in the presence of swainsonine elutes from the Bio-Gel P4 column in a position which is intermediate between that of GP, and that of normal GP2: thus, partial removal of the mannose residues from the high-mannose chains destined to become GP2 occurs also in the presence of swainsonine. In animal cells, swainsonine has been reported to inhibit a-mannosidase II but not a-mannosidase I, giving rise to structures with five mannose residues instead of only the three 'core' mannose residues ofthe usual biantennary complex chains (25) . It should be noted in this context that there is no evidence that these enzymes exist in plants. Since (Fig. 5, swainsonine) , and the difference in size between pGP2 and GP2 is much smaller than in controls. We suggest that the modified side chains of PHA carrying extra mannose residues are acceptors of only part of the GlcNAc residues which are normally attached during transport of the protein through the Golgi apparatus. The removal of these residues occurs after PHA has reached the protein bodies (28 synthesized in the presence of DONJM was treated with ,B-Nacetyl-glucosaminidase, there was no shift in the position of the peak eluting from the chromatography column (Fig. 4B) ; a small amount of radioactivity was released as free GlcNAc: this could be due to the fact that either GIcNAc residues can be attached to the glucose-containing oligosaccharide chains, although with very low efficiency, or more likely, that a small amount ofnormal pGP2 was present in the sample due to the incomplete action of the inhibitor.
In animal cells, processing of the asparagine-linked oligosaccharides is under the control of several enzymes and involves the formation of intermediate products. The conclusion ofthis study, together with the one by Hori et al. (15) , is that this is also the case for the plant cells and that several different glycosidases and glycosyltransferases are involved in this processing. The results which we have described in this paper, and those which were described previously by us (27) (28) (29) and by others using plant cells ( 13-17, 19, 24) are entirely consistent with the existence of the processing intermediates shown in Figure 7 . It should be emphasized that linkage analysis of the glycosyl residues is still needed to confirm the structure of the processing intermediates.
